Valuation : Haleon plc

Market Cap 29.49B 39.95B 34.38B 32.37B 55.18B 3,801B 55.4B 384B 148B 1,937B 150B 147B 6,135B P/E 2026 *
17.4x
P/E 2027 * 15.4x
Enterprise Value 36.39B 49.3B 42.42B 39.94B 68.09B 4,691B 68.36B 473B 183B 2,390B 185B 181B 7,571B EV / Sales 2026 *
3.2x
EV / Sales 2027 * 3.02x
Free-Float
98.46%
Yield 2026 *
2.41%
Yield 2027 * 2.67%

Last Transcript : Haleon plc

1 day-0.36%
1 week-6.71%
Current month-9.40%
1 month-8.65%
3 months-1.33%
6 months-10.56%
Current year-10.99%
1 week 333.1
Extreme 333.1
361.85
1 month 333.1
Extreme 333.1
374.6
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 58 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
5/19/26 Others 4,415 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-6.71%-8.60%+2.71% 39.95B
+0.03%-3.09%+49.77%+91.69% 1,002B
-0.76%-2.95%+50.93%+66.34% 644B
+0.86%-4.13%+19.24%+68.37% 443B
-0.82%-2.92%+30.06%+36.31% 343B
+1.29%-13.84%+12.31%+28.12% 262B
-0.14%-4.01%-2.14%+11.02% 245B
-0.48%-11.65%+39.75%+50.82% 212B
-0.29%-4.31%-17.83%-57.81% 199B
-0.68%-2.65%+25.82%+91.64% 181B
Average -0.11%-5.35%+19.93%+38.92% 356.96B
Weighted average by Cap. -0.11%-4.29%+31.76%+56.96%

Financials

2026 *2027 *
Net sales 11.39B 15.42B 13.27B 12.5B 21.3B 1,468B 21.39B 148B 57.24B 748B 57.91B 56.65B 2,369B 11.86B 16.06B 13.82B 13.01B 22.19B 1,528B 22.28B 154B 59.61B 779B 60.31B 59B 2,467B
Net income 1.69B 2.29B 1.97B 1.86B 3.17B 218B 3.18B 22.03B 8.52B 111B 8.62B 8.43B 352B 1.91B 2.59B 2.23B 2.1B 3.58B 247B 3.59B 24.89B 9.62B 126B 9.73B 9.52B 398B
Net Debt 6.9B 9.35B 8.04B 7.57B 12.91B 889B 12.96B 89.76B 34.69B 453B 35.1B 34.34B 1,435B 6.3B 8.53B 7.34B 6.91B 11.78B 812B 11.83B 81.9B 31.65B 413B 32.03B 31.33B 1,310B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-09-10 GBX 333.10 -0.51% 1,260,960
26-09-09 GBX 334.80 -0.74% 30,262,720
26-09-08 GBX 337.30 -1.75% 26,975,570
26-09-07 GBX 343.30 -2.69% 23,818,644
26-09-04 GBX 352.80 -1.34% 42,934,648
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.348GBP
Average target price
4.202GBP
Spread / Average Target
+25.52%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!